Application Information

This drug has been submitted to the FDA under the reference 012359/004.

Names and composition

"SALUTENSIN-DEMI" is the commercial name of a drug composed of HYDROFLUMETHIAZIDE and RESERPINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
012359/004 SALUTENSIN-DEMI HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 25MG and 0.125MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
012359/003 SALUTENSIN HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 50MG and 0.125MG
012359/004 SALUTENSIN-DEMI HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 25MG and 0.125MG
088110/001 HYDROFLUMETHIAZIDE AND RESERPINE HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 50MG and 0.125MG
088127/001 HYDROFLUMETHIAZIDE AND RESERPINE HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 25MG and 0.125MG
088195/001 HYDROFLUMETHIAZIDE AND RESERPINE HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 50MG and 0.125MG
088907/001 RESERPINE AND HYDROFLUMETHIAZIDE HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 50MG and 0.125MG
088932/001 RESERPINE AND HYDROFLUMETHIAZIDE HYDROFLUMETHIAZIDE; RESERPINE TABLET/ORAL 50MG and 0.125MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved